Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,041 | 84,947 | 243,693 | 198,521 | 153,678 |
| Receivables | 56,113 | 40,364 | 38,963 | 69,259 | 41,455 |
| Inventories | 24,176 | 23,098 | 22,978 | 23,468 | 24,202 |
| TOTAL | $190,061 | $165,135 | $322,359 | $307,232 | $237,481 |
| Non-Current Assets | |||||
| PPE Net | 5,690 | 5,880 | 6,197 | 6,216 | 6,563 |
| Investments And Advances | 10,698 | 5,619 | 5,556 | 5,495 | 0 |
| Intangibles | 180,897 | 187,651 | 194,403 | 201,156 | 207,908 |
| Other Non-Current Assets | 798 | 798 | 688 | 752 | 7,612 |
| TOTAL | $198,083 | $199,948 | $206,844 | $213,619 | $222,083 |
| Total Assets | $388,144 | $365,083 | $529,203 | $520,851 | $459,564 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,245 | 11,171 | 8,006 | 9,190 | 7,869 |
| Accrued Expenses | 15,127 | 12,690 | 19,634 | 12,518 | 14,380 |
| Other current liabilities | 5,821 | 3,692 | 2,876 | 2,175 | 6,243 |
| TOTAL | $37,178 | $32,111 | $34,827 | $32,351 | $66,809 |
| Non-Current Liabilities | |||||
| Long Term Debt | 291,945 | 291,456 | 290,979 | 290,516 | 196,984 |
| Deferred Revenues | 319 | 177 | 834 | 1,315 | N/A |
| Other Non-Current Liabilities | 9,417 | 9,390 | 9,142 | 8,791 | 8,291 |
| TOTAL | $311,332 | $306,624 | $320,068 | $321,401 | $247,945 |
| Total Liabilities | $348,510 | $338,735 | $354,895 | $353,752 | $314,754 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,637 | 46,552 | 46,465 | 46,457 | 45,837 |
| Common Shares | 466 | 464 | 464 | 464 | 458 |
| Retained earnings | -141,372 | -151,740 | 41,678 | 38,126 | 22,842 |
| Other shareholders' equity | 54,439 | 54,416 | 54,182 | 54,258 | 54,070 |
| TOTAL | $39,634 | $26,348 | $174,308 | $167,099 | $144,810 |
| Total Liabilities And Equity | $388,144 | $365,083 | $529,203 | $520,851 | $459,564 |